BNTX News and Press, BioNTech SE From 04/19/24

2024-04-19 06:45:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy outperfor...

2024-04-18 12:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-16 09:15:50 ET Summary PFE's dividend has reached the sky-high (for a biotech) ~6% mark. Are the dividend and recent share price decline enough to make PFE an attractive play? PFE is following a similar trajectory to GILD in its post-HCV stagnation. PFE may be wort...

2024-04-10 12:30:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. We believe internation...

Three-year follow-up data of an investigator-initiated Phase 1 trial of the individualized mRNA cancer vaccine candidate autogene cevumeran (BNT122, RO7198457) continue to show polyspecific T cell responses up to three years and delayed tumor recurrence in patients with resected pancreati...

2024-03-26 06:44:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips As we step into March 2024, the spotlight is turning towards the biotech sector, with investors searching for biotech stocks to buy. Biotech stocks are ready to soar after a period of under...

A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) rose 0.1% to $0.1331 on volume of 235,074,479 shares Jaguar Health Inc. (JAGX) rose 16.0% to $0.0799 on volume of 189,600,392 shares BYND Cannasoft Enterprises Inc. (BCAN) rose 2.5% to $0.0205 on volume of 17...

2024-03-20 14:45:11 ET Image source: The Motley Fool. BioNTech Se (NASDAQ: BNTX) Q4 2023 Earnings Call Mar 20, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: BioNTech Se (BNTX) Q4 2023 Earnings Call Transcript

2024-03-20 14:43:17 ET Summary BioNTech's Q4 earnings shows a significant revenue drop and profitability concerns, with expectations of continued vaccine demand decline. Despite short-term challenges, BioNTech's mRNA technology and pipeline, including COVID/flu vaccines and oncolo...

2024-03-20 13:30:20 ET BioNTech SE (BNTX) Q4 2023 Earnings Conference Call March 20, 2024, 08:00 AM ET Company Participants Victoria Meissner - VP, Strategy and IR Ugur Sahin - Co-Founder and CEO Ozlem Tureci - Chief Medical Officer and Co-Founder Jens Holste...